Hydra Biosciences Receives $10,507,500 New Financing

  • Feed Type
  • Date
    4/1/2015
  • Company Name
    Hydra Biosciences
  • Mailing Address
    45 Moulton Street Cambridge, MA 02138 USA
  • Company Description
    Hydra Biosciences is a biopharmaceutical company developing molecular regeneration medicines, novel cardiovascular therapies and drugs targeting novel ion channels.
  • Website
    http://www.hydrabiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,507,500
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy